Managing chronic skin conditions such as psoriasis or eczema often requires the use of long-term systemic or biological medications. These treatments work by modulating the immune system or targeting specific inflammatory pathways to achieve skin clearance. Because these medications can affect internal organs or the immune system, regular medical monitoring is a standard part of UK clinical practice. This monitoring ensures that the treatment remains effective while maintaining the safety of the patient through regular clinical assessments and laboratory tests.
What We’ll Discuss in This Article
- The clinical purpose of regular monitoring during systemic therapy.
- Frequency of blood tests for traditional systemic medications.
- Monitoring schedules for biological therapies.
- The role of baseline screening before starting a new treatment.
- Annual reviews and holistic health assessments.
- How monitoring requirements change once a patient is stabilised.
The clinical purpose of regular monitoring
Medical monitoring is required to detect potential side effects before they cause physical symptoms. Many systemic medications used in dermatology are processed by the liver or kidneys, and regular blood tests allow clinicians to monitor these organs effectively. According to NICE guidance on psoriasis, monitoring is essential to balance the benefits of treatment against potential risks. These checks also provide an opportunity for the clinician to assess the skin’s response to the medication using standardised scoring tools to ensure the treatment is working as expected.
Monitoring traditional systemic medications
The frequency of checks for traditional systemic medications like methotrexate, ciclosporin, or azathioprine is higher during the initial stages of treatment. When a patient first begins these medications, blood tests are typically performed every two weeks to monitor the full blood count and liver function as the dose is adjusted. Once the dose is stable and the patient shows no adverse effects, the frequency usually moves to once every three months. Ciclosporin requires additional monitoring of blood pressure and kidney function at each clinical visit because it can affect these systems more directly than other treatments.
Monitoring schedules for biological therapies
Biological therapies are generally more targeted than traditional systemics and often require less frequent blood monitoring once the patient is stable. After an initial screening and a review at approximately twelve weeks, most patients on biologics will have a formal medical review every six months. These reviews focus on the efficacy of the drug and screening for any signs of infection. It is a requirement in the UK to undergo screening for tuberculosis and other latent infections before starting a biologic, with some clinics performing a repeat screen annually depending on the specific medication and patient risk factors.
Baseline screening before starting therapy
Before any long-term systemic therapy begins, a comprehensive set of baseline tests is performed to ensure the patient is fit for the medication. This typically includes a full blood count, liver function tests, and renal function tests to check kidney health. For many treatments, clinicians also perform viral screening for conditions such as Hepatitis B, Hepatitis C, and HIV. This baseline data serves as a point of comparison for all future tests, allowing the medical team to identify any subtle changes in the patient’s internal health over time.
Annual reviews and holistic health assessments
In addition to regular blood tests, patients on long-term therapy should receive a comprehensive annual review. This appointment is used to evaluate the long-term impact of the treatment on the patient’s quality of life and to check for associated health risks. For example, NHS information on psoriasis highlights that chronic inflammation can be linked to cardiovascular health, so an annual review may include blood pressure checks and cholesterol screening. This is also the time when a clinician may perform a full skin check to monitor for any suspicious lesions or changes in moles, which is an important safety precaution for those on long-term immunosuppression.
Conclusion
The frequency of medical checks during long-term skin therapy is determined by the specific medication being used and how long the patient has been taking it. Initial phases require intensive monitoring, often every two weeks, while stable long-term maintenance usually requires reviews every three to six months. These regular assessments are a vital safety measure to ensure that the medication is working correctly without causing harm to internal systems. If you experience severe, sudden, or worsening symptoms, such as a high fever or significant swelling while on these treatments, call 999 immediately.
Why do I need blood tests if my skin looks clear?
Blood tests are performed to monitor the health of your internal organs, such as the liver and kidneys, which can be affected by medication even if your skin is healthy.
Can I have my monitoring tests done at my local GP surgery?
Many hospital dermatology departments set up shared care agreements that allow you to have your regular blood tests at your GP surgery once your dose is stable.
What happens if I miss a scheduled blood test?
Missing a safety monitoring test may lead to delays in your next prescription, as pharmacists and clinicians must ensure it is safe to continue the medication.
Do biologics require more frequent checks than tablets?
Generally, biological injections require less frequent blood tests than traditional tablets like methotrexate once the initial stabilising period is over.
Is blood pressure monitoring part of a skin check?
Yes, for certain medications like ciclosporin, monitoring blood pressure is a mandatory part of every clinical review to ensure cardiovascular safety.
Will I need to be screened for tuberculosis?
TB screening is a standard requirement before starting biological therapies in the UK to ensure the medication does not re-activate a dormant infection.
How long does a typical monitoring appointment take?
A standard monitoring appointment for bloods usually takes a few minutes, while a formal clinical review with a dermatologist may take fifteen to twenty minutes.
Authority Snapshot (E-E-A-T Block)
This article is designed to inform patients about the standard monitoring protocols for long-term dermatological therapies in the UK. It was written by our medical content team and reviewed by Dr. Rebecca Fernandez, a UK-trained physician with extensive experience in internal medicine and emergency care. The content is strictly aligned with the latest evidence-based safety standards provided by NHS and NICE guidance for 2026.
